Cargando…
Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen
OBJECTIVE: Acute lymphoblastic leukemia (ALL) is a malignant disease characterized by the accumulation of lymphoblasts, and a poor prognosis for adults with ALL is closely associated with disease recurrence. Thus far, treatment approaches have been limited, particularly in patients who are unable to...
Autores principales: | Xiao, XiaoFang, Ye, XingNong, Xu, Cheng, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214580/ https://www.ncbi.nlm.nih.gov/pubmed/30464503 http://dx.doi.org/10.2147/OTT.S177503 |
Ejemplares similares
-
TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
por: Lelaidier, Martin, et al.
Publicado: (2015) -
CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study
por: Qian, Jie‐Jing, et al.
Publicado: (2020) -
FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2017) -
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020) -
Erythroleukemia Relapsing as Precursor B-cell Lymphoblastic Leukemia
por: Park, Borae G., et al.
Publicado: (2011)